VIMTA LABS
Back to Income Statement
|
VIMTA LABS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹41 Cr | ₹48 Cr | ₹41 Cr | ₹21 Cr | ₹6.85 Cr |
What is the latest Consolidated Net Profit of VIMTA LABS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2024 | ₹41 Cr |
| Mar2023 | ₹48 Cr |
| Mar2022 | ₹41 Cr |
| Mar2021 | ₹21 Cr |
| Mar2020 | ₹6.85 Cr |
How is Consolidated Net Profit of VIMTA LABS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹41 Cr | -14.87 | |
| Mar2023 | ₹48 Cr | 16.55 | |
| Mar2022 | ₹41 Cr | 93.09 | |
| Mar2021 | ₹21 Cr | 212.71 | |
| Mar2020 | ₹6.85 Cr | - | |
Compare Consolidated Net Profit of peers of VIMTA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VIMTA LABS | ₹1,954.1 Cr | 3.7% | -28.1% | 2.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,559.0 Cr | 7.1% | -1.5% | -6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,827.0 Cr | 2.8% | -2.8% | 6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,942.0 Cr | 3.1% | 4.2% | 18.8% | Stock Analytics | |
| CIPLA | ₹106,825.0 Cr | 0.2% | -12.5% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,077.0 Cr | 2.2% | -1.6% | 0% | Stock Analytics | |
VIMTA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIMTA LABS | 3.7% |
-28.1% |
2.1% |
| SENSEX | 1.7% |
-1.7% |
10.3% |
You may also like the below Video Courses